For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

2021-2: Substance-Exposed Pregnancies: What to Know As They Grow

This presentation will explore how substance use during pregnancy impacts the maternal/fetal development and increases the neurological vulnerabilities of the neonate.  The unique challenges and opportunities of providing care to a substance-exposed pregnancy will be explored.  The importance of screening procedures will be discussed and how the information obtained during the screening influences the treatment plan.

Presenter: Kathleen Schachman, PhD, PMHNP-BC, FAANP, FIAAN

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off label use of medications may be discussed during this presentation.

Session Length:  47 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to: 

• Describe two ways that substance use during pregnancy impacts maternal/fetal developmental and neurological vulnerabilities of the neonate.
• Identify the unique challenges and opportunities in providing care for substance-exposed pregnancies.
• Implement screening procedures identify high-risk or problematic substance use during pregnancy.
• Plan treatment approaches to optimize maternal and neonatal outcomes.

Keywords:  Substance Use Disorder, Opioid Use Disorder, Pregnancy, Women’s Health

Price: Free

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, honor statement, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the posttest and a score of 80% is required to pass. Once you have passed and completed the evaluation and honor statement, your nursing continuing professional development certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Release date: December 1, 2021

The contact hours for this session expire: January 31, 2023

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

2021-3: A Primer on Stimulant Use Disorder: A Growing Concern

This presentation will explore stimulant use disorders in the adult population. The neuroscience changes as a result of a SUD will be explored along with the signs and symptoms that often present with the diagnosis and potential treatment options.

Presenter: Laura G Leahy, DrNP, APRN, PMH-CNS/FNP, CARN-AP, FAANP, FAAN

Disclosures: The presenter has indicated a financial interest or other affiliation with Alkermes (Vivitrol), Otsuka (Rexulti) and American Psychiatric Publishing, Inc. Off-label use of medications will be discussed during this presentation. Off label use or investigational use in the presentation include Anticonvulsants, antihypertensives and antidepressants as treatment options for substance use disorders. The activity planners have no conflicts of interest to disclose.

Session Length:  46 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss the prevalence and risks of stimulant use disorder.
• Discuss the neuroscience of stimulant use disorder.
• Discuss the neuroscience of stimulant use disorder.
• Identify potential treatments for stimulant use disorder.
  

Keywords: Stimulant Use Disorder, Substance Use Disorder, Opioid Use Disorder

Price: Free

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, honor statement, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the posttest and a score of 80% is required to pass. Once you have passed and completed the evaluation and honor statement, your nursing continuing professional development certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Funding for this initiative was made possible (in part) by grant no.1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Release date: December 1, 2021

The contact hours for this session expire: January 31, 2023

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

2021-1: What’s in Grandma’s Medicine Cabinet? – Understanding Substance Use Disorders in Older Adults

This presentation will explore substance use disorders in the older adult population, and how unique age-related physiological and social changes present unique challenges for the identification and treatment of this disorder. 

Presenter:  Kathleen Schachman, PhD, PMHNP-BC, FAANP, FIAAN

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off label use of medications will not be discussed during this presentation.

Session Length:  45 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Estimate the prevalence of substance use/misuse in older adults.
  
• Understand risk factors that may influence this population’s use/misuse of substances.
• Understand physiological differences with aging.
• List three potential treatment approaches that are safe, effective, and tailored to the unique strengths and needs of the older adult who has a substance use disorder (SUD).

Keywords:  Substance Use Disorder, Opioid Use Disorder, Older Adults

Price: Free

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, honor statement, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the posttest and a score of 80% is required to pass. Once you have passed and completed the evaluation and honor statement, your nursing continuing professional development certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Funding for this initiative was made possible (in part) by grant no.1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Release date: December 1, 2021

The contact hours for this session expire: January 31, 2023

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

2021-4: How to Accurately Assess Tobacco Use Disorder (TUD)

This presentation will review how to accurately assess TUD in patients with a diagnosis of SUD and introduce implementing a standardized TUD assessment tool.

Presenter:  Carol Essenmacher, DNP, RN, PMHCNS-BC, NCTTP

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off label use of medications will not be discussed during this presentation.

Session Length:  32 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Demonstrate use of a detailed tobacco use assessment to effectively treat TUD in patients diagnosed with a SUD. 
  

Keywords:  Substance Use Disorder, Tobacco Use Disorder

Price: Free

Nursing Continuing Professional Development:
0.5 contact hours.  * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, honor statement, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the posttest and a score of 80% is required to pass. Once you have passed and completed the evaluation and honor statement, your nursing continuing professional development certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Release date: December 3, 2021

The contact hours for this session expire: January 31, 2023

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

2021-6: Opioid Use Disorder Treatment

This presentation will explore treatment options for persons with an opioid use disorder diagnosis and the challenges for the identification and treatment of this disorder. 

Presenter: Susan Dawson, EdD, PMHNP-BC
 

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  While the use of FDA-approved medications (both generic and brand name) will be discussed, this is not an endorsement or recommendation for any commercial product. Off label use of medications will not be discussed during this presentation.

Session Length:  45 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Identify the opioid addiction assessment process and treatment options to utilize with persons who have an opioid use disorder diagnosis.
  
• Provide a focused update on successful opioid use disorder treatment protocols.
  
• Discuss methods that help clients with an opioid use disorder diagnosis adhere to treatment protocols. 
  

Keywords:  Substance Use Disorder, Opioid Use Disorder, Psychopharmacology

Price:  Free

Nursing Continuing Professional Development:
0.75 psychopharmacology contact hours.  * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, honor statement, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the posttest and a score of 80% is required to pass. Once you have passed and completed the evaluation and honor statement, your nursing continuing professional development certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Release date: December 9, 2021

The contact hours for this session expire: January 31, 2023

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

For an uninterrupted learning experience, please use Google Chrome, Safari or Firefox as your browser. If you use Internet Explorer, you may not be able to view or access parts of this course.* 

2021-5: Maximizing Pharmacological Interventions for Treating Tobacco Use Disorders (TUD); Focus on Nicotine Replacement Therapy (NRT)

This presentation will discuss the use of pharmacotherapies, specifically Nicotine Replacement Therapy (NRT), to assist a person with a diagnosis of Substance Use Disorder to quit tobacco use. The dosage of nicotine in different products will be discussed. 

Presenter: Carol Essenmacher, DNP, RN, PMHCNS-BC, NCTTP

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off label use of medications will not be discussed during this presentation.

Session Length:  25 minutes

Target Audience:  RN, APRN

Learning Outcomes:
Upon completion of this presentation, the participant will be able to:

• Demonstrate application of evidence on effective use of pharmacotherapies for TUD, focusing on clinical practice strategies using NRT to effectively treat TUD for patients living with SUD.

Keywords:  Substance Use Disorder, Tobacco Use Disorder, Psychopharmacology

Price:  Free

Nursing Continuing Professional Development:
0.5 psychopharmacology contact hours.  * In order to receive contact hours, you must: Listen to the entire session, complete an evaluation, honor statement, and earn a passing score on the post test before the expiration date. You will have 5 tries to correctly answer the questions on the posttest and a score of 80% is required to pass. Once you have passed and completed the evaluation and honor statement, your nursing continuing professional development certificate will be generated online and available for immediate printing. Credit cannot be earned unless all components of the program are completed. 

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Funding for this initiative was made possible (in part) by grant no.1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Release date:  December 8, 2021

The contact hours for this session expire:  January 31, 2023

*Internet Explorer is an outdated browser and therefore when using it, APNA eLearning Center courses often will not load or play properly. Because Internet Explorer is still the default browser on many devices, this is the number one issue that impacts learners’ ability to access their courses. For an uninterrupted learning experience, please download and use Google Chrome, Mozilla Firefox, Microsoft Edge, Safari, etc. If you continue to experience issues, you may need to update your browser.

4207-21: Implementing the Edinburgh Postnatal Depression Scale (EPDS) and Mini International Psychiatric Interview (MINI) in Each Trimester of Pregnancy to Improve Screening and Treatment of Perinatal Mood and Anxiety Disorders (PMADs)

This presentation discusses current research examining the feasibility and acceptability of implementing the Edinburgh Postnatal Depression Scale (EPDS) throughout pregnancy and the possibility of using the EPDS to identify other mental health diagnoses. A thorough review of perinatal mood and anxiety disorders (PMADS) and current practice will also be examined.

Presenters:  Aparna Kumar, PhD, CRNP; Angela Gerolamo, PhD, CRNP

Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.

Session Length:  21 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Discuss appropriate screening recommendations for perinatal mental health, and implementation of the EPDS and MINI in the clinical setting.

Keywords:  Perinatal Mental Health, Screening, Quality Improvement

Nursing Continuing Professional Development:
0.25 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 35th Annual Conference

The contact hours for this session expire:  November 30, 2024

4204-21: Does the Empirical Evidence Support the PNES Diagnosis?

An influential segment of neurology is fascinated by psychogenic seizures (PNES). The empirical evidence shows patients with seizures labelled epilepsy and patients with seizures labelled PNES are identical populations separated only by a fallible test. The condition known as PNES is just as disabling as epilepsy because it is epilepsy.

Presenter:  Catherine A. Carlson, Psy.D., LP

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.

Session Length:  39 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Assess the validity of the diagnostic entity known as PNES (psychogenic nonepileptic seizures).

Keywords:  PNES, Seizures, Epilepsy

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 35th Annual Conference

The contact hours for this session expire:  November 30, 2024

4205-21: Shared Decision Making and Decisional Conflict in Women with Postpartum Depression

This presentation discusses the use of shared decision making in the care of women experiencing postpartum depression and its effect on decisional conflict and treatment outcomes.

Presenter:  Leslie Binford, DNP, RN, PMHNP-BC

Disclosures:  The presenter and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.

Session Length:  35 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Describe the concepts of shared decision making and its influence on decisional conflict in women experiencing symptoms of postpartum depression.

Keywords:  Postpartum Depression, Shared Decision Making, Decisional Conflict

Nursing Continuing Professional Development:
0.5 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 35th Annual Conference

The contact hours for this session expire:  November 30, 2024

4201-21: Psychiatric Nursing in Early Childhood Mental Health through Primary, Secondary and Tertiary Prevention

This presentation introduces the use of the prevention intervention framework to conceptualize the role of psychiatric nurses as infant mental health practitioners or allied professionals. Participants will leave knowing how to apply the nursing process to their practice when servicing families with children ages 0-5.

Presenters:  Jessica M. Gordon, APRN, CPNP-PC; Kathy C. Gaffney, MSN, CPNP, PMHCNS; Joy A. Lauerer, DNP, PMHCNS-BC, RN

Disclosures:  The presenters and planners have no conflict of interest or commercial support to disclose.  Off-label use of medications will not be discussed during this presentation.

Session Length:  41 minutes

Target Audience:  RN, APRN

Learning Outcome:
Upon completion of this presentation, the participant will be able to:

• Implement early interventions for infant mental health disorders based on level of prevention (primary, secondary, tertiary).

Keywords:  Prevention Intervention, Infant Mental Health, Literature Review

Nursing Continuing Professional Development:
0.75 contact hours.  * In order to receive contact hours, you must: Listen to presentation, complete an evaluation, and earn a passing score on the post-test before the expiration date. You will have 5 tries to correctly answer the questions on the post-test and a score of 80% is required to pass. Once you have passed and completed an evaluation, the certificate will be generated online, available for you to print immediately. You cannot earn credit unless all steps are completed.

The American Psychiatric Nurses Association is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Originally Presented
APNA 35th Annual Conference

The contact hours for this session expire:  November 30, 2024